Effects of rAd-p53 on growth of human hepatic carcinoma cells

陶振超,钱立庭,邱俊,王明明
DOI: https://doi.org/10.19405/j.cnki.issn1000-1492.2013.04.006
2013-01-01
Abstract:Objective To explore the effect of recombinant human adenovirus p53(rAd-p53) on hepatic carcinoma cells with different p53 genetic statuses.Methods Two human hepatocellular carcinoma cell lines with different p53 genetic statuses,HepG2(WT p53) and PLC / PRF /5(MT p53),were infected with recombinant adenovirus carrying wild-typep53 gene(rAd-p53) with increasing multiplicities of infection(MOI).Cell survival was evaluated by MTT,p53 protein expression was detected by Western blot assay;and cell apoptosis was assayed by flow cytometry.Results MTT showed that cell inhibitory rates of HepG2 and PLC / PRF /5 cells,after 48 h's infection with 20 MOI values of cells,were(17.40 ± 3.01) % and(25.60 ± 3.88) %(P < 0.01),respectively.The transduction efficiency were gradually increased as the infection time or virus dosage increased.The expression of p53 protein was significantly increased in both cell lines after infection.After 48h,cell apoptosisw as assayed were(6.24 ±0.74) % and(8.31 ±0.69) %(P <0.01) by Flow Cytometry.Conclusion rAd-p53 can greatly inhibit proliferation and induce cell apoptosis.And the therapeutic efficacy of rAd-p53 in wild-type p53 hepatocellular carcinoma cells is much stronger than that in mutate hepatocellular carcinoma cells.
What problem does this paper attempt to address?